A devastating case of diarrhea-associated hemolytic uremic syndrome associated with extensive cerebral infarction; why we need to do better

References

• Nester CM, Thomas CP. Atypical hemolytic uremic syndrome: what is it, how is it diagnosed and how is it treated?. Hematol Am Soc Hematol Educ Prog. 2012;2012:617–625.
   PubMedGoogle Scholar
• Cornu G, Proesmans W, Dediste A, et al. Hemolytic uremic syndrome in Belgium: incidence and association with verocytotoxin-producing Escherichia coli infection. Clin Microbiol Infect. 1999;5(1):16–22.
   PubMedGoogle Scholar
• Salvadori M, Bertoni E. Update on hemolytic uremic syndrome: diagnostic and therapeutic recommendations. World J Nephrol. 2013;2(3): 56–76.10.5527/wjn.v2.i3.56
   PubMedGoogle Scholar
• Gould LH, Demma L, Jones TF, et al. Hemolytic uremic syndrome and death in persons with Escherichia coli O157:H7 infection, foodborne diseases active surveillance network sites, 2000–2006. Clin Infect Dis. 2009;49(10):1480–1485.10.1086/599193
   PubMed Web of Science ®Google Scholar
• Gillespie RS. Pediatric hemolytic uremic syndrome. [cited 2017 Jan 12]. Available from: https://www.medscape.com
   Google Scholar
• Nathanson S, Kwon T, Elmaleh M, et al. Acute neurological involvement in diarrhea-associated hemolytic uremic syndrome. Clin J Am Soc Nephrol. 2010;5(7):1218–1228.10.2215/CJN.08921209
   PubMed Web of Science ®Google Scholar
• Robson WL, Leung AK, Trevenen CL, et al. Diarrhea-associated hemolytic uremic syndrome. Can Fam Physician. 1993;39:2139–2145.
   PubMed Web of Science ®Google Scholar
• Hahn JS, Havens PL, Higgins JJ, et al. Neurological complications of hemolytic-uremic syndrome. J Child Neurol. 1989;4(2):108–113.10.1177/088307388900400206
   PubMed Web of Science ®Google Scholar
• Cimolai N, Morrison BJ, Carter JE. Risk factors for the central nervous system manifestations of gastroenteritis-associated hemolytic uremic syndrome. Pediatrics. 1992;90:616–622.
   PubMed Web of Science ®Google Scholar
• Garg AX, Suri RS, Barrowman N, et al. Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression. JAMA. 2003;290(10):1360–1370.10.1001/jama.290.10.1360
   PubMed Web of Science ®Google Scholar
• Gitiaux C, Krug P, Grevent D, et al. Brain magnetic resonance imaging pattern and outcome in children with haemolytic-uraemic syndrome and neurological impairment treated with eculizumab. Dev Med Child Neurol. 2013;55(8):758–765.
   PubMed Web of Science ®Google Scholar
• Ammon A. Surveillance of enterohaemorrhagic E. coli (EHEC) infections and haemolytic uraemic syndrome (HUS) in Europe. Euro Surveill. 1997;2:91–96.
   PubMedGoogle Scholar
• Altmann M, Wadl M, Altmann D, et al. Timeliness of Surveillance during outbreak of shiga toxin-producing Escherichia coli infection, Germany. Emerg Infect Dis. 2011;17(10):1906–1909.10.3201/eid1710.111027
   PubMed Web of Science ®Google Scholar
• European Center for disease prevention and control. Annual epidemiological report Food-and waterborne diseases and zoonoses 2014. [cited 2016 Sep 10]. Available from: https://www.ecdc.europa.eu
   Google Scholar
• Smith DR. Vaccination of Cattle against Escherichia coli O157:H7. Microbiol Spectr. 2014;2(6). DOI: 10.1128/microbiolspec.EHEC-0006-2013
   PubMedGoogle Scholar
• Ake JA, Jelacic S, Ciol MA, et al. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion. Pediatrics. 2005;115(6):e673–e680.10.1542/peds.2004-2236
   PubMed Web of Science ®Google Scholar
• Ardissino G, Tel F, Possenti I, et al. Early volume expansion and outcomes of hemolytic uremic syndrome. Pediatrics. 2016;137(1). DOI: 10.1542/peds.2015-2153
   PubMed Web of Science ®Google Scholar
• Boyce TG, Swerdlow DL, Griffin PM. Escherichia coli O157:H7 and the hemolytic-uremic syndrome. N Engl J Med. 1995;333(6):364–368.10.1056/NEJM199508103330608
   PubMed Web of Science ®Google Scholar
• Rizzoni G, Claris-Appiani A, Edefonti A, et al. Plasma infusion for hemolytic-uremic syndrome in children: results of a multicenter controlled trial. J Pediatr. 1988;112(2):284–290.10.1016/S0022-3476(88)80071-4
   PubMed Web of Science ®Google Scholar
• Colic E, Dieperink H, Titlestad K, et al. Management of an acute outbreak of diarrhoea-associated haemolytic uraemic syndrome with early plasma exchange in adults from southern Denmark: an observational study. Lancet. 2011;378(9796):1089–1093.10.1016/S0140-6736(11)61145-8
   PubMed Web of Science ®Google Scholar
• Menne J, Nitschke M, Stingele R, et al. Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study. BMJ. 2012;19(345):e4565.10.1136/bmj.e4565
   Web of Science ®Google Scholar
• Karpman D. Management of Shiga toxin-associated Escherichia coli-induced haemolytic uraemic syndrome: randomized clinical trials are needed. Nephrol Dial Transplant. 2012;27(10):3669–3674.10.1093/ndt/gfs456
   PubMed Web of Science ®Google Scholar
• Greinacher A, Friesecke S, Abel P, et al. Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4-associated haemolytic uraemic syndrome: a prospective trial. The Lancet. 2011;378(9797):1166–1173.10.1016/S0140-6736(11)61253-1
   PubMed Web of Science ®Google Scholar
• Perez N, Spizzirri F, Rahman R, et al. Steroids in the hemolytic uremic syndrome. Pediatr Nephrol. 1998;12(2):101–104.10.1007/s004670050413
   PubMed Web of Science ®Google Scholar
• Pape L, Hartmann H, Bange FC, et al. Eculizumab in typical hemolytic uremic syndrome (HUS) with neurological involvement. Medicine (Baltimore). 2015;94(24):e1000.10.1097/MD.0000000000001000
   PubMed Web of Science ®Google Scholar
• Keir LS, Marks SD, Kim JJ. Shigatoxin-associated hemolytic uremic syndrome: current molecular mechanisms and future therapies. Drug Des Devel Ther. 2012;6:195–208.
   PubMed Web of Science ®Google Scholar
• Keenswijk W, Vanmassenhove J, Raes A, et al. Blood urea nitrogen to serum creatinine ratio is an accurate predictor of outcome in diarrhea-associated hemolytic uremic syndrome, a preliminary study. Eur J Pediatr. 2017;176(3):355–360.10.1007/s00431-016-2846-z
   PubMed Web of Science ®Google Scholar